1 |
Bork PM, Schmitz ML, Kuhnt M, Escher C, Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett. 1997. 402: 85-90.
DOI
ScienceOn
|
2 |
Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov. 2003. 2: 179-191.
DOI
ScienceOn
|
3 |
Green SJ, Meltzer MS, Hibbs JB Jr., Nacy CA. Activated macro-phages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990. 144: 278-283.
|
4 |
Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol. 1990. 42: 553-557.
DOI
|
5 |
Grzanna R, Lindmark L, Frondoza CG. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005. 8: 125-132.
DOI
ScienceOn
|
6 |
Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit. 2001. 7: 801-819.
|
7 |
Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, Schulze-Osthoff K, Droge W, Schmitz ML. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem. 1998. 273: 1288-1297.
DOI
|
8 |
Heinrich M, Robles M, West JE, Ortiz de Montellano BR, Rodriguez E. Ethnopharmacology of Mexican asteraceae (Compositae). Annu Rev Pharmacol Toxicol. 1998. 38: 539-565.
DOI
ScienceOn
|
9 |
Heinrich M, Robles M, West JE, Ortiz de Montellano BR, Rodriguez E. Ethnopharmacology of Mexican asteraceae (Compositae). Annu Rev Pharmacol Toxicol. 1998. 38: 539 -565.
DOI
ScienceOn
|
10 |
Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG. Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis. 2001. 184: 330-336.
DOI
ScienceOn
|
11 |
Lee AN, Park SJ, Jeong AR, Lee JR, Park HJ, Kim SJ, Min IS, Youn HS. Ovalbumin induces cycloxygenase-2 and inducible nitric oxide synthase expression. Korean J Food Sci Technol. 2011. 43: 110-113.
|
12 |
Lee AN, Park SJ, Yun SM, Lee MY, Son BS, Youn HS. Parthenolide Suppresses the Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Induced by Toll-Like Receptor 2 and 4 Agonists. J. Exp. Biomed Sci. 2010. 16: 39-45.
|
13 |
Mine Y, Yang M. Recent advances in the understanding of egg allergens: basic, industrial, and clinical perspectives. J Agric Food Chem. 2008. 56: 4874-4900.
DOI
ScienceOn
|
14 |
Moncada S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med. 1999. 92: 164-169.
|
15 |
Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988. 2: 189-192.
|
16 |
Oka D, Nishimura K, Shiba M, Nakai Y, Arai Y, Nakayama M, Takayama H, Inoue H, Okuyama A, Nonomura N. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer. 2007. 120: 2576-2581.
DOI
ScienceOn
|
17 |
Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun. 1993. 193: 398-405.
DOI
ScienceOn
|
18 |
Park SJ, Shin HJ, Youn HS. Parthenolide inhibits TRIF-dependent signaling pathway of Toll-like receptors in RAW264.7 macrophages. Mol Cells. 2011. 31: 261-265.
DOI
ScienceOn
|
19 |
Schinella GR, Giner RM, Recio MC, Mordujovich de Buschiazzo P, Rios JL, Manez S. Anti-inflammatory effects of South American Tanacetum vulgare. J Pharm Pharmacol. 1998. 50: 1069-1074.
DOI
ScienceOn
|
20 |
Sheehan M, Wong HR, Hake PW, Malhotra V, O'Connor M, Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol. 2002. 61: 953-963.
DOI
ScienceOn
|
21 |
Siriwatanametanon N, Fiebich BL, Efferth T, Prieto JM, Heinrich M. Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol. 2010. 130: 196-207.
DOI
ScienceOn
|
22 |
Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003. 3: 768-780.
DOI
ScienceOn
|
23 |
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001. 480: 243-268.
|
24 |
Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002. 53: 35-57.
DOI
ScienceOn
|
25 |
Vallance P. Nitric oxide: therapeutic opportunities. Fundam Clin Pharmacol. 2003. 17: 1-10.
DOI
ScienceOn
|
26 |
Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998. 38: 97-120.
DOI
ScienceOn
|
27 |
Yang EJ, Chang JH. The extract of Pseudomonas aeruginosa induces the apoptosis of the human colorectal cancer cell line, HCT 116 cells, via mitochondrial pathway. J Exp Biomed Sci. 2012. 18: 16-21.
|
28 |
Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol. 2005. 175: 3339-3346.
|
29 |
Zhao L, Lee JY, Hwang DH. Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. Nutr Rev. 2011. 69: 310-320.
DOI
ScienceOn
|
30 |
Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med. 2003. 31: S105-111.
DOI
ScienceOn
|